
The Journey from Machine Learning to Agentic AI in Clinical Trials
Clinical trials are experiencing a major transformation. While the core goal remains bringing safe, effective treatments to patients, how we reach that goal is changing
Webinar | Why 95% of AI Projects Stall – and How Agentic AI Changes the Game
Transforming Data into Systems of Action
A Saama company that offers data analytics solutions and services for banking and capital markets, consumer goods, insurance, the public sector, and more.

Clinical trials are experiencing a major transformation. While the core goal remains bringing safe, effective treatments to patients, how we reach that goal is changing

When it comes to clinical trial data, consistency is everything. That’s where the Study Data Tabulation Model (SDTM), developed by the Clinical Data Interchange Standards

The stakes in clinical research have never been higher. While breakthrough treatments show tremendous promise, the reality is sobering: bringing a single drug to market

Healthcare data generates an astonishing 30% of the world’s total data, yet 80% of it remains unstructured- trapped in clinical notes, research papers, and disparate

Artificial Intelligence (AI) and Machine Learning (ML) have become key players in reshaping how we develop drugs, but with this potential comes the critical need

We’ll be covering the best practices for training AI models for life sciences, from data preparation to training methods, and more.

Today we’ll be looking at AI’s applicability across clinical data management (CDM) in life sciences and how it improves CDM as a business process. Artificial Intelligence

No matter what your core focus is as a life sciences organization, manual data review is laborious and time-consuming, and vulnerable to human errors. A

Patients’ safety is the top priority in any clinical trial. The data safety and monitoring services (DSMC) are there to ensure that the clinical studies
Get our perspectives on AL/ML in the life sciences industry directly to your inbox.